By Buy This GLP Editorial Team · Editorial profile: Carla Medina
REMEVi review
Current four-week options
REMEVi’s current dedicated pricing page lists different rates from its older product and location pages.
A comparable monthly medication price is not available. See the plan details below for published fees, medication costs and payment terms.
The bottom line
REMEVi’s published pricing page lists injectable semaglutide at $143 and tirzepatide at $224 on the flexible plan. Its FAQ says the plan renews every four weeks. Older published rate pages show different amounts.
Disclosure: Buy This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
What the figure does not cover
Fees, terms and cancellation at REMEVi
- Cancellation
- The pricing FAQ says the flexible plan renews every four weeks until canceled. Check the selected offer and the refund conditions for prepaid plans.
Pricing transparency
How REMEVi publishes its prices
To compare four-week fills with calendar-month prices, use the exact amount confirmed for your offer. Thirteen payments at the current published rates average about $155 and $243 per calendar month. Shapely’s four-week medication charges show how a separate monthly care fee can change that annual calculation. Longer terms are prepaid and have different rates.
At a glance
- Category
- GLP-1 pricing
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- States
- 51
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
The seller
What REMEVi is
REMEVi lists compounded injection and oral offers, with prices that differ between public pages.
How it works
Confirm the program the checkout uses before comparing the price on its dedicated pricing page with another offer.
Branded or compounded
Compounded medications are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness or quality.
Where the money holds, and where it moves
Predictable
- Publishes information about its weight-management program
Moves, or is not stated
- The selected offer determines the exact billing terms
Who this is worth it for
People who can verify the exact four-week offer before enrollment.
Who should price elsewhere
People who need a single renewal price across public REMEVi routes.
The molecules
What REMEVi prescribes, and the evidence for it
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Oral Semaglutide vs Injection: Wegovy Doses and Trial Results
In the US, Wegovy tablet maintenance is 25 mg daily. The usual recommended injection dose is 2.4 mg weekly for adults managing weight.
- Is Tirzepatide Worth the Extra Cost Over Semaglutide?
Average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide in a head-to-head trial. A separate observational study found an uncertain difference in cardiovascular outcomes.
Priced against
Sellers to price beside REMEVi
TMates
People who can confirm the commitment and total for their selected product.
See TMates →
VoxyPeople comparing published monthly and prepaid charges for Voxy
See Voxy →Tonik Wellness
People comparing clearly disclosed billing periods and totals.
See Tonik Wellness →
More GLP-1 sellers by price priced end to end: CabanaCaliberRxCalibrate HealthCalifornia Trim ClinicCall-On-DocCandor Rx
Sponsored alternative
SkinnyRx
Buyers choosing tirzepatide who want its standing rate before an intake
Check SkinnyRx availability →Provider information
Plans and terms behind the assessment
Checked . Confirm current terms before paying.
Or go back to the price desk and compare REMEVi against every seller on it.